-
SUTRA: A Novel Approach to Modelling Pandemics with Applications to COVID-19
Authors:
Manindra Agrawal,
Madhuri Kanitkar,
Deepu Phillip,
Tanima Hajra,
Arti Singh,
Avaneesh Singh,
Prabal Pratap Singh,
Mathukumalli Vidyasagar
Abstract:
The Covid-19 pandemic has two key properties: (i) asymptomatic cases (both detected and undetected) that can result in new infections, and (ii) time-varying characteristics due to new variants, Non-Pharmaceutical Interventions etc. We develop a model called SUTRA (Susceptible, Undetected though infected, Tested positive, and Removed Analysis) that takes into account both of these two key propertie…
▽ More
The Covid-19 pandemic has two key properties: (i) asymptomatic cases (both detected and undetected) that can result in new infections, and (ii) time-varying characteristics due to new variants, Non-Pharmaceutical Interventions etc. We develop a model called SUTRA (Susceptible, Undetected though infected, Tested positive, and Removed Analysis) that takes into account both of these two key properties. While applying the model to a region, two parameters of the model can be learnt from the number of daily new cases found in the region. Using the learnt values of the parameters the model can predict the number of daily new cases so long as the learnt parameters do not change substantially. Whenever any of the two parameters changes due to the key property (ii) above, the SUTRA model can detect that the values of one or both of the parameters have changed. Further, the model has the capability to relearn the changed parameter values, and then use these to carry out the prediction of the trajectory of the pandemic for the region of concern. The SUTRA approach can be applied at various levels of granularity, from an entire country to a district, more specifically, to any large enough region for which the data of daily new cases are available.
We have applied the SUTRA model to thirty-two countries, covering more than half of the world's population. Our conclusions are: (i) The model is able to capture the past trajectories very well. Moreover, the parameter values, which we can estimate robustly, help quantify the impact of changes in the pandemic characteristics. (ii) Unless the pandemic characteristics change significantly, the model has good predictive capability. (iii) Natural immunity provides significantly better protection against infection than the currently available vaccines.
△ Less
Submitted 25 October, 2022; v1 submitted 22 January, 2021;
originally announced January 2021.
-
Modeling polypharmacy side effects with graph convolutional networks
Authors:
Marinka Zitnik,
Monica Agrawal,
Jure Leskovec
Abstract:
The use of drug combinations, termed polypharmacy, is common to treat patients with complex diseases and co-existing conditions. However, a major consequence of polypharmacy is a much higher risk of adverse side effects for the patient. Polypharmacy side effects emerge because of drug-drug interactions, in which activity of one drug may change if taken with another drug. The knowledge of drug inte…
▽ More
The use of drug combinations, termed polypharmacy, is common to treat patients with complex diseases and co-existing conditions. However, a major consequence of polypharmacy is a much higher risk of adverse side effects for the patient. Polypharmacy side effects emerge because of drug-drug interactions, in which activity of one drug may change if taken with another drug. The knowledge of drug interactions is limited because these complex relationships are rare, and are usually not observed in relatively small clinical testing. Discovering polypharmacy side effects thus remains an important challenge with significant implications for patient mortality. Here, we present Decagon, an approach for modeling polypharmacy side effects. The approach constructs a multimodal graph of protein-protein interactions, drug-protein target interactions, and the polypharmacy side effects, which are represented as drug-drug interactions, where each side effect is an edge of a different type. Decagon is developed specifically to handle such multimodal graphs with a large number of edge types. Our approach develops a new graph convolutional neural network for multirelational link prediction in multimodal networks. Decagon predicts the exact side effect, if any, through which a given drug combination manifests clinically. Decagon accurately predicts polypharmacy side effects, outperforming baselines by up to 69%. We find that it automatically learns representations of side effects indicative of co-occurrence of polypharmacy in patients. Furthermore, Decagon models particularly well side effects with a strong molecular basis, while on predominantly non-molecular side effects, it achieves good performance because of effective sharing of model parameters across edge types. Decagon creates opportunities to use large pharmacogenomic and patient data to flag and prioritize side effects for follow-up analysis.
△ Less
Submitted 26 April, 2018; v1 submitted 1 February, 2018;
originally announced February 2018.
-
Large-scale analysis of disease pathways in the human interactome
Authors:
Monica Agrawal,
Marinka Zitnik,
Jure Leskovec
Abstract:
Discovering disease pathways, which can be defined as sets of proteins associated with a given disease, is an important problem that has the potential to provide clinically actionable insights for disease diagnosis, prognosis, and treatment. Computational methods aid the discovery by relying on protein-protein interaction (PPI) networks. They start with a few known disease-associated proteins and…
▽ More
Discovering disease pathways, which can be defined as sets of proteins associated with a given disease, is an important problem that has the potential to provide clinically actionable insights for disease diagnosis, prognosis, and treatment. Computational methods aid the discovery by relying on protein-protein interaction (PPI) networks. They start with a few known disease-associated proteins and aim to find the rest of the pathway by exploring the PPI network around the known disease proteins. However, the success of such methods has been limited, and failure cases have not been well understood. Here we study the PPI network structure of 519 disease pathways. We find that 90% of pathways do not correspond to single well-connected components in the PPI network. Instead, proteins associated with a single disease tend to form many separate connected components/regions in the network. We then evaluate state-of-the-art disease pathway discovery methods and show that their performance is especially poor on diseases with disconnected pathways. Thus, we conclude that network connectivity structure alone may not be sufficient for disease pathway discovery. However, we show that higher-order network structures, such as small subgraphs of the pathway, provide a promising direction for the development of new methods.
△ Less
Submitted 3 December, 2017;
originally announced December 2017.
-
Effect of macromolecular crowding on the rate of diffusion-limited enzymatic reaction
Authors:
Manish Agrawal,
S. B. Santra,
Rajat Anand,
Rajaram Swaminathan
Abstract:
The cytoplasm of a living cell is crowded with several macromolecules of different shapes and sizes. Molecular diffusion in such a medium becomes anomalous due to the presence of macromolecules and diffusivity is expected to decrease with increase in macromolecular crowding. Moreover, many cellular processes are dependent on molecular diffusion in the cell cytosol. The enzymatic reaction rate ha…
▽ More
The cytoplasm of a living cell is crowded with several macromolecules of different shapes and sizes. Molecular diffusion in such a medium becomes anomalous due to the presence of macromolecules and diffusivity is expected to decrease with increase in macromolecular crowding. Moreover, many cellular processes are dependent on molecular diffusion in the cell cytosol. The enzymatic reaction rate has been shown to be affected by the presence of such macromolecules. A simple numerical model is proposed here based on percolation and diffusion in disordered systems to study the effect of macromolecular crowding on the enzymatic reaction rates. The model explains qualitatively some of the experimental observations.
△ Less
Submitted 19 July, 2008;
originally announced July 2008.
